Lam Research pairs indispensable etch leadership and recurring service revenue with AI-driven WFE growth, but China exposure and cyclical execution leave meaningful downside around a premium valuation.
Overview
Lam Research supplies wafer-fabrication equipment and lifetime services across deposition, etch, and clean processes. Its FY2026 revenue mix was 64.1% Systems and 35.9% recurring-oriented CSBG, supported by a global installed base above 90,000 chambers. Technical leadership in high-aspect-ratio etch, process IP, and customer qualification makes Lam a critical supplier to TSMC, Samsung, SK Hynix, Micron, and Intel; it holds over 45% of plasma-etch share. **AI-driven device complexity and a projected WFE step-up—from the mid-$150 billion range in 2026 to more than $200 billion in 2027—are the central growth catalysts.** Q1 FY2027 revenue rose 54.4% year over year to a record $8.22 billion, non-GAAP gross margin reached 52.4%, operating margin was 40.2%, and free cash flow was $3.24 billion. Q2 guidance calls for $8.60 billion revenue ± $400 million, with supply constraints pushing some shipments into March. At $228.95 after a roughly 6%–10.8% post-earnings decline, shares traded at approximately 24.1x FY2027 and 19.1x FY2028 consensus EPS, versus a probability-weighted five-year target of $331.22. Near-term catalysts are shipment catch-up, memory recovery, HBM and advanced-packaging demand, and adoption of Aether and Akara; China controls and AI-spending digestion are material offsets.